Form 4: U.S. Physical Therapy Executive Acquires Shares and Modifies Vesting Terms

Richard Binstein, EVP, General Counsel & Secretary of U.S. Physical Therapy, acquired shares of common stock and amended the vesting terms of outstanding awards.

Summary

• Richard Binstein, an executive at U.S. Physical Therapy, filed a Form 4 indicating changes in beneficial ownership.
• He acquired 8,100 shares of common stock as restricted stock under the company's Amended and Restated 2003 Stock Incentive Plan.
• These shares vest in 15 equal quarterly installments, starting May 20, 2025, and continuing through March 6, 2029, contingent upon his continued employment.
• The vesting terms of 9,177 outstanding unvested shares were also amended on February 24, 2025, with revised vesting dates in 2025, 2026, 2027 and 2028.
• Following the reported transactions, Binstein beneficially owns 19,867 shares of common stock.

Sentiment

Score: 6

Explanation: The document reflects standard executive compensation practices. It's neutral in sentiment, indicating routine transactions.

Positives

• The grant of restricted stock aligns the executive's interests with those of the shareholders.
• The vesting schedule incentivizes continued employment and contribution to the company's success.

Risks

• The vesting of the restricted stock is contingent upon continued employment, creating a potential risk if the executive leaves the company before all shares vest.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the restricted stock.

Industry Context

Executive stock grants and vesting schedules are common practices in the healthcare industry to incentivize and retain key personnel. This filing reflects standard compensation practices.

Comparison to Industry Standards

• Stock grants to executives are a common practice across publicly traded companies, including those in the physical therapy and rehabilitation sector.
• Companies like ATI Physical Therapy and Select Medical Holdings also utilize equity-based compensation to align executive interests with shareholder value.
• The vesting schedules are generally in line with industry norms, typically ranging from three to five years with quarterly or annual vesting intervals.

Stakeholder Impact

• The stock grant aligns executive interests with shareholder value, potentially benefiting shareholders.
• The vesting schedule incentivizes the executive to remain with the company, which could benefit employees and customers through continued leadership.

Key Dates